HPV16 E6 oncoprotein stimulates the transforming growth factor-β1 promoter in fibroblasts through a specific GC-rich sequence

Virology

Volumn 228, Issue 2, 1997, Pages 190-199

  Dey, Arunangsu ^a   Atcha, Irfan A ^a   Bagchi, Srilata ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FIBROBLAST; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; ONCOGENE; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HUMAN ADENOVIRUS TYPE 12; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0031575532     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8363     Document Type: Article

References (44)

1. Arroyo M., Raychaudhuri P. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein. Nucleic Acids Res. 20:1992;5947-5954.
2. Baker C. C., Phelps W. C., Lindgren V., Braun M. J., Gonda M. A., Howley P. M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:1987;962-971.
3. Borellini F., Glazer R. I. Induction of Sp1-p53 binding heterocomplexes during granulocyte/macrophage colony stimulating factor dependent proliferation in human erythroleukemia cell line TF1. J. Biol. Chem. 268:1993;7923-7928.
4. Chellappan S., Kraus V. B, Kroger B., Munger K., Howley P. M., Phelps W. C., Nevins J. R. Adenovirus E1A, simian virus 40 T antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA. 89:1992;4549-4553.
5. Crook T., Tidy J. A., Vousden K. H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53-binding and transactivation. Cell. 67:1991;547-556.
6. Courey A. J., Tjian R. Transcriptional regulation. 1993;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 743-779.
7. Datta P., Bagchi S. Repression of the transforming growth factor β1 promoter by the adenovirus oncogene E1A. Identification of a unique GC-rich sequence as a target for E1A repression. J. Biol. Chem. 269:1994;25392-25399.
8. Datta P., Raychaudhuri P., Bagchi S. Association of p107 with Sp1: Genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription. Mol. Cell. Biol. 15:1995;5444-5452.
9. DeCaprio J. A., Ludlow J. W., Figge J., Shew J. Y., Lee C. M., Marsilio E., Paucha E., Livingston D. M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 54:1988;275-283.
10. Desaintes C., Hallez S., Van Alphen P., Burney A. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol. 66:1992;325-333.
11. Dyson N., Howley P. M., Munger K., Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937.
12. Fisch T. M., Prywes R., Roeder R. G. c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O. Mol. Cell. Biol. 7:1987;3490-3502.
13. Gualberto A., Baldwin A. S. Jr. p53 and Sp1 interact and co-operate in the tumor necrosis factor induced transcriptional activation of the HIV long terminal repeat. J. Biol. Chem. 270:1995;19680-19683.
14. Geiser A. G., Kim S. J., Roberts A. B., Sporn M. B. Characterization of the mouse transforming growth factor B1 promoter and activation by the Ha-ras oncogene. Mol. Cell. Biol. 11:1991;84-92.
15. Hagen G., Muller S., Beato M., Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13:1994;3843-3851.
16. Halbert C. L., Demers G. W., Galloway D. A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:1991;473-478.
17. Hawley-Nelson P., Vousden K. H., Hubbert N. l., Lowy D. R., Schiller J. T. HPV16 E6 and E7 cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:1989;3905-3910.
18. Heibert S., Chellapan S. P., Horowitz J. M., Nevins J. R. Interaction of Rb with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:1992;177-185.
19. Kim S. J., Glick A., Sporn M. B., Roberts A. B. Characterization of the promoter region of the human transforming growth factor-β1 gene. J. Biol. Chem. 264:1989;402-408.
20. Kim S. J., Angel P., Lafyatis R., Hattori K., Kim K. Y., Sporn M. B., Karin M., Roberts A. B. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1990;1492-1497.
21. Kim S. J., Lee H. D., Robbins P. D., Busam K., Sporn M. B., Roberts A. B. Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma susceptibility gene. Proc. Natl. Acad. Sci. USA. 88:1991;3052-3056.
22. Kingsley C., Winoto A. Cloning of GT box-binding proteins: A novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell Biol. 12:1992;4251-4261.
23. Ko L. J., Prives C. p53: Puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
24. Lamberti C., Morrissey L. C., Grossman S. R., Androphy E. J. Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. EMBO J. 9:1990;1907-1913.
25. Levine A. The tumor suppressor genes. Annu. Rev. Biochem. 62:1993;623-651.
26. Lyons R. M., Moses H. L. Transforming growth factors and regulation of cell proliferation. Eur. J. Biochem. 187:1990;467-473.
27. Mansur C. P., Androphy E. J. Cellular transformation by papillomavirus oncoproteins. Biochem. Biophys. Acta. 1155:1993;323-345.
28. Massague J. The transforming growth factor β-family. Annu. Rev. Cell. Biol. 6:1990;597-641-51.
29. Morsov A., Phelps C. W., Raychaudhuri P. Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60. J. Biol. Chem. 269:1994;18434-18440.
30. Munger K., Phelps W. C., Bubb V., Howley P. M., Schlegel. The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:1989;4417-4421.
31. Nevins J. R. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:1992;424-442.
32. Phelps W. C., Yee C. L., Munger K., Howley P. M. The human papillomavirus type 16 E7 gene codes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 53:1988;539-547.
33. Phelps W. C., Bagchi S., Barnes J. A., Raychaudhuri P., Munger K., Howley P. M., Nevins J. R. Analysis of transactivation by human papillomavirus type 16 E7 and adenovirus 12S EIA suggests a common mechanism. J. Virol. 65:1992;6922-6930.
34. Reznikoff C. A., Belair C., Savelieva E., Zhai Y., Pfeifer K., Yeager T., Thompson K. J., De Vries S., Brindley C., Newton M. A., Sekhon G., Waldman F. Long-term genome stability and minimal genotypic and phenotypic alterations in HPV 16 E7- but not E6- immortalized human uroepithelial cells. Genes Dev. 8:1994;2227-2240.
35. Roberts A. B., Sporn M. B. Sporn M. B., Roberts A. B. Peptide Growth Factors and Their Receptors. 1990;421-429 Springer-Verlag KG, Heidelberg.
36. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
37. Sedman S. A., Barbosa M. S., Vass W. C., Hubbert N. L., Haas J. A., Lowy D. R., Schiller J. T. The full-length E6 protein of human papillomavirus type 16 has transforming and transactivating activities and co-operates with E7 to immortalize keratinocytes in culture. J. Virol. 65:1991;4860-4866.
38. Vousden K. H. Regulation of cell cycle by viral oncoproteins. Semin. Cancer. Biol. 6:1995;109-116.
39. Wazer D. E., Liu X-L., Chu Q., Gao Q., Band V. Immortalization of distinct human mammary epithelial cell types by human papillomavirus 16 E6 or E7. Proc. Natl. Acad. Sci. USA. 92:1995;3687-3691.
40. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
41. White A. E., Livanos E. M., Tlsty T. D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes. Dev. 8:1994;666-677.
42. Whyte P., Buchkovich J. J., Horowitz J. M., Friend S. H., Raybuck M., Weinberg R. A., Harlow E. Association between an oncogene and an anti-oncogene. The adenovirus E1A proteins binds to the retinoblastoma gene product. Nature. 334:1988;124-129.
43. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virol. 184:1991;9-13.
44. zur Hausen H., de Villiers E.-M. Human papillomaviruses. Annu. Rev. Microbiol. 48:1994;427-447.